Hims & Hers Health, Inc. (NYSE:HIMS) stock tanked around 26% on Friday after the U.S. FDA announced that the shortage of semaglutide injection products has been resolved. Data by YCharts Semaglutide ...
Hosted on MSN46m
Eli Lilly shares climb for seven consecutive sessionsEli Lilly (NYSE:LLY) shares rose for seven straight sessions, as the stock ended 1.5% higher at $915.2 on Wednesday. The U.S. pharmaceutical giant gained over 5% in the preceding six sessions. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback